XBI.MX SPDR Series Trust - SPDR S&P Biotech ETF

ETF Healthcare Equity SPDR State Street Global Advisors Mexican Exchange
- MXN
No recent price
Total assets
188B
Expense ratio
0.35%
Dividend yield
0.10%
1-year return
+36.59%
Holdings
10
Since
2006

Fund data as reported by the issuer, updated Nov 7, 2026. Total assets are in the fund's base currency.

What does XBI.MX invest in?

Tracks Morningstar US Health TR USD
  • Mostly US stocks (100.4%)
  • Largest sector: Healthcare (104.3%)
  • Largest region: North America (94.9%)
  • Top 3 holdings: 6.0% of the fund

Asset allocation

  • US stocks 100.4%
  • Non-US stocks 3.2%

Top holdings

  • Moderna Inc 2.30%
  • Natera Inc 1.87%
  • Twist Bioscience Corp 1.81%
  • Amgen Inc 1.80%
  • Halozyme Therapeutics Inc 1.80%
All holdings, sectors and regions

SPDR Series Trust - SPDR S&P Biotech ETF performance

Sharpe ratio 0.91
This year
+25.73%
1 year
+36.59%
3 years
+36.41%
5 years
+0.36%

Volatility 25.4% over 1 year and 26.9% over 3 years. High: expect large swings.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

XBI.MX price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About SPDR Series Trust - SPDR S&P Biotech ETF

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).

Full fund profile